For example, According to one study, DNMT1-mediated FOXO3a promoter hypermethylation reduces FOXO3a expression in breast cancer, and FOXO3a decreases breast cancer stem cell characteristics and tumorigenicity through lowering FOXM1/SOX2 signaling (Liu et al., 2020). This evidence concerns the gene FOXO3 and breast carcinoma.